Due to a current patent legal dispute, Myco has temporarily stopped selling the ABMax device and tips in the United States. Myco hopes to resolve this issue shortly so it can continue to offer its high-quality ABMax products in the United States.
Provides Better Outcomes and Higher Profits
John Choate, Chairman of Myco Industries and one of the inventors of the first doctor’s treatment for blepharitis has designed the AB Max™ with advanced functionality utilizing two on-board computers and proprietary tips specifically designed to treat Anterior Blepharitis*.
The AB Max™ provides the same forward and reverse functionality as our competitor’s device PLUS, a patented PULSE mode specifically engineered to remove even the most tenacious scurf and debris, while gently massaging the anterior eyelid margins for better patient outcomes.
The AB Max™ not only provides you with the most advanced treatment for Anterior Blepharitis*, it also adds to your profit margin and has a significantly better Return on Investment (ROI). The AB Max™ handpiece is less than one third the cost of the competition’s device with our procedure packs costing less than half.